Microorganisms and antimicrobial resistance in HAIs
The online database of the ECDC HAI-Net point prevalence survey (PPS) of healthcare-associated infections (HAIs) and antimicrobial use provides European reference data on HAIs and antimicrobial use in acute care hospitals in Europe. See the PPS reports on microorganisms and antimicrobial resistance in HAIs
Antimicrobial resistance surveillance in Europe 2011
This report presents antimicrobial resistance data for seven invasive pathogens of major public health importance: Streptococcus pneumoniae, Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, Enterococcus faecium, Klebsiella pneumoniae and Pseudomonas aeruginosa.
European surveillance of Clostridium difficile infections - surveillance protocol version 2.3
This updated protocol prescribes the methodology, and provides the data collection tools required to achieve the objectives of European surveillance of CDIs.
Rapid risk assessment: Risk related to the use of ‘do-it-yourself' CRISPR-associated gene engineering kit contaminated with pathogenic bacteria
On 24 March 2017, the German authorities reported the contamination of a ‘do-it-yourself’ bacterial gene engineering CRISPR kit produced in the US. This publication assesses the risk related to the use of ‘do-it-yourself’ CRISPR-associated gene engineering kit contaminated with pathogenic bacteria.
European Antibiotic Awareness Day: new website, new online resources
The new European Antibiotic Awareness Day (EAAD) website is a more dynamic and easy-to-access hub for resources to raise awareness about prudent use of antibiotics and about antibiotic resistance.
ECDC, EFSA and EMA Joint Scientiﬁc Opinion on a list of outcome indicators as regards surveillance of antimicrobial resistance and antimicrobial consumption in humans and food-producing animals
ECDC, EFSA and EMA have jointly established a list of harmonised outcome indicators to assist EU Member States in assessing their progress in reducing the use of antimicrobials and antimicrobial resistance (AMR) in both humans and food-producing animals.
ECDC country visit to Luxembourg to discuss antimicrobial resistance issues
An ECDC team conducted visits and meetings to the country on 29 May - 2 June 2017, with the objective of providing an evidence-based assessment of the situation. Antibiotic consumption in Luxembourg is at the EU average in hospitals, but higher than the EU average in the community. The AMR levels in bacterial isolates from humans are at or below the EU average.
ECDC country visit to Spain to discuss antimicrobial resistance issues
On 15-19 February 2016 an ECDC team conducted visits and meetings to discuss AMR issues in Spain, with the overall objective of providing an evidence-based assessment of the situation in Spain. The AMR situation in Spain poses a major public health threat to the country. Antimicrobial consumption in primary care and hospitals is among the highest in the EU/EEA and infection prevention and control and environmental cleaning measures vary significantly among hospitals and units.